Jeff Yass’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-23,600
Closed -$3.22M 12070
2020
Q3
$3.22M Sell
23,600
-101,600
-81% -$10.8M ﹤0.01% 3737
2020
Q2
$12.1M Sell
125,200
-374,300
-75% -$31.2M ﹤0.01% 1919
2020
Q1
$23.4M Buy
499,500
+445,400
+823% +$28.5M 0.01% 1080
2019
Q4
$3.94M Buy
54,100
+4,700
+10% +$285K ﹤0.01% 3312
2019
Q3
$2.58M Buy
49,400
+25,500
+107% +$1.36M ﹤0.01% 3746
2019
Q2
$1.2M Sell
23,900
-26,200
-52% -$1.28M ﹤0.01% 5247
2019
Q1
$2.6M Sell
50,100
-19,900
-28% -$917K ﹤0.01% 3367
2018
Q4
$3.42M Sell
70,000
-20,700
-23% -$1.14M ﹤0.01% 2747
2018
Q3
$5.91M Buy
90,700
+36,700
+68% +$2.16M ﹤0.01% 2481
2018
Q2
$2.68M Buy
54,000
+33,100
+158% +$1.6M ﹤0.01% 3558
2018
Q1
$1.02M Buy
+20,900
New +$1.09M ﹤0.01% 5203

Jeff Yass's MYOK Position: Q4 2020 in Review

Jeff Yass sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 20,088 shares — an estimated $2.74M sold.

Jeff Yass first reported a position in MYOK in Q4 2015 and held it in 10 quarters. The position peaked at $8.61M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Jeff Yass reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Jeff Yass sold 20,088 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.74M.
  • Jeff Yass first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
  • Jeff Yass's MyoKardia, Inc. Common Stock position peaked at $8.61M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.